TGA
- Status: likely_approved
🇦🇺 Blujepa in Australia
Blujepa (GEPOTIDACIN) regulatory status in Australia.
Marketing authorisations
TGA
- Status: likely_approved
Blujepa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Australia
Frequently asked questions
Is Blujepa approved in Australia?
Yes. TGA has authorised it; TGA has authorised it.
Who is the marketing authorisation holder for Blujepa in Australia?
Glaxosmithkline is the originator. The local marketing authorisation holder may differ — check the official source linked above.